The federal contract IDV award is for the procurement of Oseltamivir Phosphate capsules and suspension by the Department of Veterans Affairs (VA) National Acquisition Center. This is a single-award, unrestricted contract with an estimated ceiling value of $10,164,262.95. The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida, that specializes in manufacturing, distributing, and repackaging pharmaceutical medications for various federal healthcare agencies, including the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service.
The contract has a one-year base period with four one-year option periods, allowing for long-term, stable supply arrangements. Exelan will provide an uninterrupted supply of Oseltamivir Phosphate capsules in 30mg, 45mg, and 75mg dosages, as well as Oseltamivir Phosphate suspension in 6mg/mL, to support the VA's, DoD's, Bureau of Prisons', and Indian Health Service's pharmaceutical requirements. The contract will be fulfilled through the VA's and DoD's Pharmaceutical Prime Vendor Programs, ensuring the continued availability of these critical medications for veterans, military personnel, and other federal beneficiaries.
Generated 2/4/25, 10:20 AM